Oracle (NYSE:ORCL – Get Free Report) had its price objective lowered by equities researchers at Citizens Jmp from $342.00 to $285.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “market outperform” rating on the enterprise software provider’s stock. Citizens Jmp’s price target indicates a potential upside of 104.18% from the stock’s previous close.
ORCL has been the topic of several other reports. Wells Fargo & Company began coverage on Oracle in a research note on Wednesday, December 3rd. They set an “overweight” rating and a $280.00 target price on the stock. KeyCorp cut their price target on shares of Oracle from $350.00 to $300.00 and set an “overweight” rating on the stock in a report on Thursday, December 11th. Stifel Nicolaus decreased their price objective on Oracle from $350.00 to $275.00 and set a “buy” rating for the company in a report on Thursday, December 11th. Royal Bank Of Canada restated a “sector perform” rating on shares of Oracle in a research report on Monday. Finally, Erste Group Bank cut Oracle from a “buy” rating to a “hold” rating in a report on Monday, November 10th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $295.72.
View Our Latest Stock Report on ORCL
Oracle Stock Down 4.8%
Oracle (NYSE:ORCL – Get Free Report) last posted its earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The company had revenue of $16.06 billion for the quarter, compared to analyst estimates of $16.19 billion. During the same quarter in the previous year, the firm earned $1.47 earnings per share. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. As a group, equities analysts forecast that Oracle will post 5 earnings per share for the current fiscal year.
Insider Transactions at Oracle
In other news, insider Mark Hura sold 15,000 shares of Oracle stock in a transaction dated Wednesday, December 24th. The stock was sold at an average price of $196.89, for a total value of $2,953,350.00. Following the completion of the transaction, the insider owned 234,077 shares in the company, valued at approximately $46,087,420.53. This trade represents a 6.02% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Clayton M. Magouyrk sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $192.52, for a total transaction of $1,925,200.00. Following the sale, the chief executive officer owned 144,030 shares in the company, valued at $27,728,655.60. The trade was a 6.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 62,223 shares of company stock worth $12,136,764 in the last ninety days. 40.90% of the stock is owned by company insiders.
Institutional Trading of Oracle
Several institutional investors and hedge funds have recently made changes to their positions in the company. HFM Investment Advisors LLC increased its position in shares of Oracle by 290.9% in the fourth quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider’s stock valued at $25,000 after buying an additional 96 shares in the last quarter. Winnow Wealth LLC purchased a new position in Oracle during the 2nd quarter valued at about $28,000. FSA Wealth Management LLC purchased a new stake in shares of Oracle in the third quarter valued at about $28,000. Joseph Group Capital Management purchased a new position in shares of Oracle during the 4th quarter worth approximately $29,000. Finally, Kilter Group LLC acquired a new position in shares of Oracle in the second quarter worth $30,000. 42.44% of the stock is owned by hedge funds and other institutional investors.
Key Oracle News
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle continues to win commercial and public-sector AI work and reported solid Q2 results (revenue +14% YoY, EPS beat), which supports medium‑term growth expectations. Quiver Quantitative Summary
- Positive Sentiment: Oracle Health picked up a multi‑organization clinical AI pilot in Canada, demonstrating product traction in healthcare AI (could underpin recurring software/license revenue). PR Newswire: Oracle Health Pilot
- Positive Sentiment: Large institutional investors (Price T Rowe, UBS, Fidelity, Vanguard, BlackRock) have added sizeable ORCL positions recently, signaling continued long‑term conviction among some big holders. Quiver Quantitative: Institutional Moves
- Neutral Sentiment: Analysts remain mixed but skew positive overall (many buy/outperform ratings and high median targets), even as some firms trim targets — so the selloff is partly about timing and financing structure rather than a unanimous change in fundamentals. Quiver Quantitative: Analyst Snapshot
- Negative Sentiment: Oracle announced plans to raise roughly $45–50 billion to build AI data centers (mix of debt, equity and equity‑linked offerings). Investors fear dilution from equity sales and strain on leverage from big new debt, prompting the recent decline. Quiver Quantitative: Capital Raise Coverage
- Negative Sentiment: Oracle has already tapped the debt markets (large senior notes issuance) and reports say banks are seeking buyers for loans tied to Oracle’s data‑center financing — signals that the deal flow and credit placement are complex and adding short‑term risk. TipRanks: Banks Sell Data Center Loans
- Negative Sentiment: Several analysts cut price targets (e.g., Scotiabank to $220; BMO trimmed its target), and some technical traders warn key supports have been breached — increasing downside risk near short‑term technical levels. InsiderMonkey: Scotiabank Cut
- Negative Sentiment: Multiple securities‑class action filings and investor alerts have been announced alleging misstatements around the period tied to Oracle’s funding/offering disclosures — legal risk can pressure sentiment and create litigation overhang. PR Newswire: Investor Alert / Lawsuit
- Negative Sentiment: Heavy insider selling (multiple executive sales reported) and media reports about potential large layoffs add to near‑term negative sentiment. Quiver Quantitative: Insider Trading
Oracle Company Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Recommended Stories
- Five stocks we like better than Oracle
- The day the gold market broke
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
